[HTML][HTML] Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention

B Pabla, M Bissonnette, VJ Konda - World journal of clinical …, 2015 - ncbi.nlm.nih.gov
Colorectal cancer represents the third most common and the second deadliest type of
cancer for both men and women in the United States claiming over 50000 lives in 2014. The …

[HTML][HTML] MicroRNA, nutrition, and cancer prevention

SA Ross, CD Davis - Advances in nutrition, 2011 - Elsevier
MicroRNA (miRNA) are small noncoding RNA molecules that are involved in post-
transcriptional gene silencing. Alterations in miRNA expression are observed in and may …

Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes

Z Banikazemi, HA Haji, M Mohammadi… - Journal of cellular …, 2018 - Wiley Online Library
Cancer is one of main health public problems worldwide. Several factors are involved in
beginning and development of cancer. Genetic and internal/external environmental factors …

PDGFA‐associated protein 1 is a novel target of c‐Myc and contributes to colorectal cancer initiation and progression

HY Cui, W Wei, MR Qian, RF Tian, X Fu… - Cancer …, 2022 - Wiley Online Library
Background The mechanism underlying colorectal cancer (CRC) initiation and progression
remains elusive, and overall survival is far from satisfactory. Previous studies have shown …

EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators

H Zhu, U Dougherty, V Robinson, R Mustafi… - Molecular cancer …, 2011 - AACR
Epidermal growth factor receptors (EGFR) contribute to colonic tumorigenesis in
experimental models of colon cancer. We previously showed that EGFR was also required …

[HTML][HTML] EGFR in tumor-associated myeloid cells promotes development of colorectal cancer in mice and associates with outcomes of patients

S Srivatsa, MC Paul, C Cardone, M Holcmann… - Gastroenterology, 2017 - Elsevier
Background & Aims Inhibitors of the epidermal growth factor receptor (EGFR) are the first-
line therapy for patients with metastatic colorectal tumors without RAS mutations. However …

Dietary walnut suppression of colorectal cancer in mice: Mediation by miRNA patterns and fatty acid incorporation

MA Tsoukas, BJ Ko, TR Witte, F Dincer… - The Journal of nutritional …, 2015 - Elsevier
Colorectal cancer, unlike many other malignancies, may be preventable. Recent studies
have demonstrated an inverse association between nut consumption and incidence of colon …

[HTML][HTML] Epidermal growth factor receptor inhibits colitis-associated cancer in mice

PE Dubé, F Yan, S Punit, N Girish… - The Journal of …, 2012 - Am Soc Clin Investig
Inflammatory bowel disease (IBD) is a chronic illness caused by complex interactions
between genetic and environmental factors that propagate inflammation and damage to the …

[HTML][HTML] Human colorectal cancer from the perspective of mouse models

M Stastna, L Janeckova, D Hrckulak, V Kriz, V Korinek - Genes, 2019 - mdpi.com
Colorectal cancer (CRC) is a heterogeneous disease that includes both hereditary and
sporadic types of tumors. Tumor initiation and growth is driven by mutational or epigenetic …

ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer

R Mustafi, U Dougherty, D Mustafi… - Clinical Cancer …, 2017 - AACR
Purpose: Epidermal growth factor receptors (EGFR) are required for tumor promotion by
Western diet. The metalloprotease, ADAM17 activates EGFR by releasing pro-EGFR …